PSME3 and neoplasm: In summary, the naturally derived, tumor-primed TILN clones showed a broad heterogeneity of response patterns, ranging from overall very poor responders (group 1) to peptide Ki affinity-dependent (group 3) and independent (group 2) responders when tested against a panel of Ki affinity-matured peptide variants.